Indole-3-Carbinol Effects on Estrogen Metabolism
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00988845 |
Recruitment Status :
Terminated
(Slow accrual in the high BMI group)
First Posted : October 2, 2009
Last Update Posted : December 13, 2019
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Obesity | Dietary Supplement: Indole-3-carbinol | Phase 2 |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 38 participants |
Allocation: | N/A |
Intervention Model: | Single Group Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Prevention |
Official Title: | Effects of Dietary Indole-3-Carbinol on Estrogen Metabolites Across a Wide Range of Body Mass Index: Implications for the Prevention of Endometrial Cancer in Obese Women |
Study Start Date : | September 2009 |
Actual Primary Completion Date : | July 2010 |
Actual Study Completion Date : | January 2014 |
Arm | Intervention/treatment |
---|---|
Experimental: Indole-3-carbinol |
Dietary Supplement: Indole-3-carbinol
200 mg bid po X 8 weeks |
- Change in urinary 2/16-hydroxyestrone ratio [ Time Frame: 8 weeks ]
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 30 Years to 50 Years (Adult) |
Sexes Eligible for Study: | Female |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- woman aged from 30 - 50 years
- regular menstrual cycle
Exclusion Criteria:
- taking hormone replacement or hormonal contraception
- thyroid disorder
- uncontrolled asthma
- BMI under 18.5
- allergy to cruciferous vegetables
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00988845
United States, Wisconsin | |
University of Wisconsin | |
Madison, Wisconsin, United States, 53792 |
Principal Investigator: | Joseph P Connor, MD | University of Wisconsin, Madison |
Responsible Party: | University of Wisconsin, Madison |
ClinicalTrials.gov Identifier: | NCT00988845 |
Other Study ID Numbers: |
H-2009-0093 CC09709 ( Other Identifier: UW Carbone Cancer Center ) A532800 ( Other Identifier: UW Madison ) SMPH\OBSTET & GYNECOL\OB-GYN ( Other Identifier: UW Madison ) |
First Posted: | October 2, 2009 Key Record Dates |
Last Update Posted: | December 13, 2019 |
Last Verified: | April 2015 |
dietary supplement indole 3 carbinol estrogen |
Indole-3-carbinol Anticarcinogenic Agents Protective Agents Physiological Effects of Drugs Antineoplastic Agents |